Bendamustine Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-103

This text appears to be a description of a drug called "Bendamustine HCI for Injection, USP" by Meitheal Pharmaceuticals. Each vial contains 25mg of the drug and 42.5mg of mannitol. It is recommended to be reconstituted with 5mL of Sterile Water for Injection, USP and should be used within 2-3 hours after reconstitution. The drug is for intravenous infusion only and is a cytotoxic agent used for cancer treatment. Detailed instructions for reconstitution and dilution are mentioned in the insert. The text also mentions precautions for handling and preparing the drug. The storage temperature and conditions are also mentioned, along with the information about the container and the manufacturer.*

This is a description of a medication known as Bendamustine HCI for injection. Each vial contains 100mg of Bendamustine HCI, USP and 170mg of mannitol, USP. The drug is a cytotoxic agent for intravenous infusion only. The drug requires reconstitution with 20 mL of sterile water for injection before use and the final solution must be used within 24 hours when stored refrigerated or within 3 hours when stored at room temperature. The medication should be handled with caution and safety gloves and glasses should be used to avoid exposure. The Meitheal Pharmaceuticals manufactured the drug, and the product should be retained in the carton until the time of use and discard unused portions.*